Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PTrana Meditama Metropolitan TbkISX:SAME -0.65%79 Median PS Value is Rp394.19 as of Jul. 17, 2026, which is 100% below its 10-year median of 0.77. GuruFocus rates ISX:SAME with a GF Score™ of 79/100 and a GF Value™ of Rp355.08 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 262 Healthcare Providers & Services companies, PTrana Meditama Metropolitan Tbk ranks worse than 57.63% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for PTrana Meditama Metropolitan Tbk's Median PS Value or its related term are showing as below:
ISX:SAME'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.63 Med: 0.77 Max: 0.93
Current: 0.78
During the past 13 years, the highest Price to Median PS Value of PTrana Meditama Metropolitan Tbk was 0.93. The lowest was 0.63. And the median was 0.77.
ISX:SAME's Price-to-Median-PS-Value is ranked worse than 57.63% of 262
companies
in the Healthcare Providers & Services industry
Industry Median: 0.71
vs ISX:SAME: 0.78
PTrana Meditama Metropolitan Tbk (ISX:SAME) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
PTrana Meditama Metropolitan Tbk's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
306.00
/
394.19
=
0.78
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PTrana Meditama Metropolitan Tbk Median PS Value Related Terms
PTrana Meditama Metropolitan Tbk Median PS Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PTrana Meditama Metropolitan Tbk Median PS Value Chart
ISX:SAME vs HCA, THC, DVA: Median PS Value Comparison
For the Medical Care Facilities subindustry, PTrana Meditama Metropolitan Tbk's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PTrana Meditama Metropolitan Tbk Price-to-Median-PS-Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PTrana Meditama Metropolitan Tbk's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where PTrana Meditama Metropolitan Tbk's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 3.5596.
PTrana Meditama Metropolitan Tbk's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp110.739.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PTrana Meditama Metropolitan Tbk (ISX:SAME) has a Median PS Value of Rp394.19 as of Jul. 17, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on PTrana Meditama Metropolitan Tbk and its competitors. This is 51094% above median its historical median of 0.77. Over the past decade, PTrana Meditama Metropolitan Tbk's Median PS Value has ranged from 0.63 to 0.93. According to the industry distribution chart, PTrana Meditama Metropolitan Tbk ranks #151 out of 262 companies in the Healthcare Providers & Services industry, placing it in the top 57.6%.
Is PTrana Meditama Metropolitan Tbk's Median PS Value too high?
PTrana Meditama Metropolitan Tbk's current Median PS Value of Rp394.19 is 51094% above median its 10-year median of 0.77. Over the past 10 years, this metric has ranged from a low of 0.63 to a high of 0.93. Based on the distribution chart, PTrana Meditama Metropolitan Tbk ranks #151 out of 262 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, PTrana Meditama Metropolitan Tbk has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PTrana Meditama Metropolitan Tbk's Median PS Value compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PTrana Meditama Metropolitan Tbk ranks #151 out of 262 companies for Median PS Value. This places PTrana Meditama Metropolitan Tbk in the lower half of its industry. The industry median Median PS Value is 0.71. Historically, PTrana Meditama Metropolitan Tbk's own Median PS Value has ranged from 0.63 to 0.93 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Healthcare Providers & Services company?
The median Median PS Value among Healthcare Providers & Services companies is 0.71, based on 262 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on PTrana Meditama Metropolitan Tbk and its competitors. For the Healthcare Providers & Services industry, the median Median PS Value is 0.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PTrana Meditama Metropolitan Tbk's current Median PS Value is Rp394.19, which is 51094% above median its own 10-year median of 0.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PTrana Meditama Metropolitan Tbk stock overvalued right now?
Based on GuruFocus' analysis, PTrana Meditama Metropolitan Tbk (ISX:SAME) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp355.08, compared to a current price of Rp306.00 — trading 13.8% below its estimated fair value. The current Median PS Value is Rp394.19, which is 51094% above median its 10-year median of 0.77. PTrana Meditama Metropolitan Tbk's overall GF Score™ is 79/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For PTrana Meditama Metropolitan Tbk (ISX:SAME), the current Median PS Value is Rp394.19 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PTrana Meditama Metropolitan Tbk (ISX:SAME) Overvalued in 2026?
Based on GuruFocus' analysis, PTrana Meditama Metropolitan Tbk stock appears to be undervalued.
The current stock price of Rp306.00 is trading 13.8% below its estimated GF Value™ of Rp355.08.
GuruFocus considers PTrana Meditama Metropolitan Tbk to be Modestly Undervalued.
Key valuation signals for ISX:SAME:
Median PS Value: Rp394.19 (51094% above median its 10-year median of 0.77)
GF Value™: Rp355.08 vs. price of Rp306.00 (13.8% below fair value)
No single metric tells the full story. See the ISX:SAME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PTrana Meditama Metropolitan Tbk Business Description
PT Sarana Meditama Metropolitan Tbk is engaged in managing hospitals. Its hospitals are operated under the brand name Omni Hospital. The company manages and evaluates its business based on its geographic location consisting of Omni Pulomas, Omni Alam Sutera, Omni Cikarang, OMNI Pekayon, and others. It operates in Banten, DKI Jakarta, and West Java.
79GF Score
Get the complete analysis for ISX:SAME
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:SAME has been successfully added to your 
